Mazidi, Mohsen
Wright, Neil
Yao, Pang
Kartsonaki, Christiana
Millwood, Iona Y.
Fry, Hannah
Said, Saredo
Pozarickij, Alfred
Pei, Pei
Chen, Yiping
Wang, Baihan
Avery, Daniel
Du, Huaidong
Schmidt, Dan Valle
Yang, Ling
Lv, Jun
Yu, Canqing
Sun, DianJianYi
Chen, Junshi
Hill, Michael
Peto, Richard
Collins, Rory
Bennett, Derrick A.
Walters, Robin G.
Li, Liming
Clarke, Robert https://orcid.org/0000-0002-9802-8241
Chen, Zhengming
,
Funding for this research was provided by:
Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z)
National Natural Science Foundation of China (82192901, 82192904, 82192900)
Key Research and Development Program of China (2016YFC0900500)
Medical Research Council (MC_UU_00017/1, MC_UU_12026/2, MC_U137686851)
Cancer Research UK (C16077/A29186, C500/A16896)
British Heart Foundation (CH/1996001/9454)
GlaxoSmithKline and UK MRC (MC-PC-13049, MC-PC-14135)
Article History
Received: 13 March 2024
Accepted: 21 October 2024
First Online: 22 November 2024
Declarations
:
: None of the authors have any conflicts of interest in relation to this report.
: The China Kadoorie Biobank (CKB) complies with all required ethical standards for medical research on human subjects. Ethical approvals were obtained and been maintained by the relevant institutional ethical research committees in the UK and China.
: All participants provided written informed consent.